Latest News and Press Releases
Want to stay updated on the latest news?
-
BAMBERG, S.C., Oct. 07, 2021 (GLOBE NEWSWIRE) -- As the manufacturing supply chain continues to experience the pain associated with shipping delays, material shortages and significant inflation,...
-
REDWOOD CITY, Calif., Sept. 15, 2021 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a clinical-stage precision oncology company focused on developing targeted drugs to inhibit...
-
FRISCO, Texas, Sept. 09, 2021 (GLOBE NEWSWIRE) -- Inc. magazine has ranked DKBinnovative as No. 2,397 on its annual Inc. 5000 list, the most prestigious ranking of the nation's fastest-growing...
-
REDWOOD CITY, Calif., Sept. 07, 2021 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a clinical-stage precision oncology company focused on developing targeted drugs to inhibit...
-
BOSTON, Aug. 17, 2021 (GLOBE NEWSWIRE) -- Inc. Magazine today revealed that Risk Strategies, a leading national specialty insurance brokerage and risk management firm, is No. 2374 on its annual Inc....
-
AUSTIN, Texas, Aug. 17, 2021 (GLOBE NEWSWIRE) -- SecureLink, a leader in third-party security, ranked 2645 on Inc. Magazine’s 2021 list of the fastest-growing private companies in the United States....
-
LEWES, Del., Aug. 17, 2021 (GLOBE NEWSWIRE) -- Intel 471, the premier provider of cybercrime intelligence for leading intelligence, security, and fraud teams, today revealed that it has earned a...
-
Company Shows Continued Progress Demonstrating Differentiation of RAS(ON) Inhibitors, Targeting Additional RAS Variants and Progressing Assets Toward the Clinic Initial Results of RMC-4630-02 Study...
-
REDWOOD CITY, Calif., Aug. 04, 2021 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a clinical-stage precision oncology company focused on developing targeted drugs to inhibit...
-
REDWOOD CITY, Calif., May 18, 2021 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a clinical-stage precision oncology company developing targeted therapies to inhibit frontier...